Canada Markets closed

GBS Inc. (GBS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.2200-0.0100 (-0.45%)
At close: 4:00PM EDT
2.2100 -0.01 (-0.45%)
After hours: 07:56PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.2300
Open2.2400
Bid2.1900 x 3200
Ask2.2400 x 1000
Day's Range2.2000 - 2.2500
52 Week Range2.0800 - 14.2400
Volume119,911
Avg. Volume720,178
Market Cap27.488M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    GBS Inc. Announces its Pre-Submission package is with the FDA

    NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced it has filed a Pre-Submission package with the United States (US) Food and Drug Administration (FDA). The purpose of this pre-submission is to confirm with the FDA that GBS is following the proper steps to conduct the clinical studies enabling it to develop the glucos

  • GlobeNewswire

    GBS Inc. to Present at Upcoming September Virtual Investor Conferences

    H.C. Wainwright 23rd Global Investor Conference: September 13th - 15th Benzinga Healthcare Small Cap Conference: September 29th - 30th NEW YORK, Sept. 07, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced its participation in the following investor conferences in the month of September and invites investors to join virtually. H.C. Wainwrigh

  • GlobeNewswire

    GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights

    - Awarded $4.7 Million Government Grant Funding to support the building of a high-tech manufacturing facility - - Signs Strategic Partnerships with Johns Hopkins University, Wyss Institute from Harvard University, University of Newcastle and Precision Medical Architects - - $12.7 Million in Cash, Cash Equivalents, and Marketable Securities as of June 30, 2021, Provides Runway into 4Q 2022 – -To Host Conference Call and Webcast Today at 4:30 p.m. ET- NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- GB